Frontier Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atlanta (Georgia) [US], August 10 (ANI/PRNewswire): Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candidate, FB2001 - a small molecule inhibitor of coronavirus main protease (Mpro) - in healthy adult volunteers. The data, presented today at the poster session of the 11th International Conference on Emerging Infectious Diseases (ICEID), showed FB2001 to be safe and well tolerated among trial participants. Adve...

Clinical trial results showed that China's first domestically developed drug for the treatment of HI

China's first domestically developed anti-HIV drug clinically safe, effective: study-

Beijing, Jun 22 (EFE).- The first drug developed in China for the treatment of HIV has proved to be safe and effective in the results of clinical trials, state-owned Xinhua agency reported Wednesday. Aikening, or albuvirtide (ABT) is a generic drug belonging to a group of anti-HIV drugs called a fusion inhibitor, which block the …

27.04.2022 MIG Capital continues to grow after excellent financial year 2021 | Biontech | Creative Balloons | Hemovent